|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
109.12(B) |
Last
Volume: |
5,365,633 |
Avg
Vol: |
8,385,378 |
52
Week Range: |
$48.64 - $77.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
304,513 |
503,645 |
1,002,990 |
2,126,174 |
Total Sell Value |
$22,679,618 |
$34,760,114 |
$61,125,774 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
26 |
44 |
80 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nicholas Peter M |
Director |
|
2009-11-05 |
4 |
S |
$7.94 |
$2,000,540 |
D/D |
(250,000) |
10,198,610 |
|
- |
|
Kucheman William |
SVP & Group President |
|
2009-11-02 |
4 |
D |
$8.21 |
$16,945 |
D/D |
(2,064) |
36,993 |
|
- |
|
Kucheman William |
SVP & Group President |
|
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
39,057 |
|
- |
|
Mcfaul David W |
Senior VP International |
|
2009-11-02 |
4 |
D |
$8.21 |
$6,896 |
D/D |
(840) |
39,692 |
|
- |
|
Mcfaul David W |
Senior VP International |
|
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,645 |
40,532 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
100,000 |
12,184,478 |
|
- |
|
Abele John E |
Director |
|
2009-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
225,000 |
4,237,749 |
|
- |
|
Pucel Kenneth |
EVP, Operations |
|
2009-11-02 |
4 |
D |
$8.21 |
$16,945 |
D/D |
(2,064) |
50,492 |
|
- |
|
Pucel Kenneth |
EVP, Operations |
|
2009-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
52,556 |
|
- |
|
Mcfaul David W |
Senior VP International |
|
2009-10-30 |
4 |
D |
$8.12 |
$24,060 |
D/D |
(2,963) |
37,887 |
|
- |
|
Mcfaul David W |
Senior VP International |
|
2009-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,332 |
40,850 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2009-10-30 |
4 |
D |
$8.12 |
$8,510 |
D/D |
(1,048) |
19,328 |
|
- |
|
Onuscheck John Michael |
SVP & Pres-Neuromodulation |
|
2009-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
20,376 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-29 |
4 |
S |
$8.21 |
$410,280 |
I/I |
(50,000) |
12,084,478 |
|
- |
|
Abele John E |
Director |
|
2009-10-29 |
4 |
S |
$8.21 |
$1,029,143 |
I/I |
(125,000) |
4,012,749 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-28 |
4 |
S |
$8.22 |
$411,075 |
I/I |
(50,000) |
12,134,478 |
|
- |
|
Abele John E |
Director |
|
2009-10-28 |
4 |
S |
$8.22 |
$823,055 |
I/I |
(100,000) |
4,137,749 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-27 |
4 |
S |
$8.43 |
$421,475 |
I/I |
(50,000) |
12,184,478 |
|
- |
|
Abele John E |
Director |
|
2009-10-27 |
4 |
S |
$8.43 |
$843,660 |
I/I |
(100,000) |
4,237,749 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-26 |
4 |
S |
$8.50 |
$424,920 |
I/I |
(50,000) |
12,234,478 |
|
- |
|
Abele John E |
Director |
|
2009-10-26 |
4 |
S |
$8.49 |
$861,835 |
I/I |
(100,000) |
4,337,749 |
|
- |
|
Abele John E |
Director |
|
2009-10-23 |
4 |
S |
$8.55 |
$861,605 |
I/I |
(100,000) |
4,437,749 |
|
- |
|
Abele John E |
Director |
|
2009-10-22 |
4 |
S |
$8.40 |
$420,000 |
I/I |
(50,000) |
4,537,749 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(71,879) |
12,284,478 |
|
- |
|
Nicholas Peter M |
Director |
|
2009-10-21 |
4 |
AS |
$8.35 |
$417,645 |
I/I |
(50,000) |
12,428,087 |
|
- |
|
1823 Records found
|
|
Page 48 of 73 |
|
|